Investing With IBD cover image

Ep 187: Dr. Thomas Carr: Faith In Trends And The Next Bull Market

Investing With IBD

CHAPTER

Lenzax's Earnings Estimate Revisions Are Good News for Investors

I'm looking for fairly liquid stocks, 500,000 shares per day or more of a price of $15 or above. And then here is where we can insert some, at least potential for earnings estimate revisions. The estimates that they have established for the company are larger than they were last year. So I want to see that at least a 1% for this year and next year. If both of those are blue, that's a big thumbs up. Now, if it can pull back into the previous pivot highs that I see, you'll see there with a short blue line, just above $70 per share. But man, if you're in a bear market and the index is

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner